Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process.

Stewart B, Lepola P, Egger GF, Ali F, Allen AJ, Croker AK, Davidson AJ, Dicks P, Faust SN, Green D, Hovinga C, Klein AV, Langham R, Nakamura H, Pioppo L, Ramroop S, Sakiyama M, Sanchez Vigil de la Villa I, Sato J, Snyder DL, Turner MA, Zaidi S, Zimmerman K, Lacaze-Masmonteil T

Open source

DOI: 10.3389/fmed.2025.1542408
Published: 2025
Container: Frontiers in medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1542408,
  title = {Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process.},
  author = {Stewart B and Lepola P and Egger GF and Ali F and Allen AJ and Croker AK and Davidson AJ and Dicks P and Faust SN and Green D and Hovinga C and Klein AV and Langham R and Nakamura H and Pioppo L and Ramroop S and Sakiyama M and Sanchez Vigil de la Villa I and Sato J and Snyder DL and Turner MA and Zaidi S and Zimmerman K and Lacaze-Masmonteil T},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1542408},
  url = {https://doi.org/10.3389/fmed.2025.1542408}
}

RIS

TY  - JOUR
TI  - Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process.
AU  - Stewart B
AU  - Lepola P
AU  - Egger GF
AU  - Ali F
AU  - Allen AJ
AU  - Croker AK
AU  - Davidson AJ
AU  - Dicks P
AU  - Faust SN
AU  - Green D
AU  - Hovinga C
AU  - Klein AV
AU  - Langham R
AU  - Nakamura H
AU  - Pioppo L
AU  - Ramroop S
AU  - Sakiyama M
AU  - Sanchez Vigil de la Villa I
AU  - Sato J
AU  - Snyder DL
AU  - Turner MA
AU  - Zaidi S
AU  - Zimmerman K
AU  - Lacaze-Masmonteil T
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1542408
UR  - https://doi.org/10.3389/fmed.2025.1542408
ER  -

APA

B, S., P, L., GF, E., F, A., AJ, A., AK, C., AJ, D., P, D., SN, F., D, G., C, H., AV, K., R, L., H, N., L, P., S, R., M, S., I, S. V. D. L. V., J, S., DL, S., MA, T., S, Z., K, Z., & T, L. (2025). Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1542408

Source records

pubmed · retrieved 2026-09-25T08:40:07.473Z